Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Gen Surg Vivassurgical-critical-care

Gen Surg Vivas · surgical-critical-care

Damage control resuscitation in the bleeding trauma patient — ratio, clock, calcium, whole blood and limits

Fellowship viva on damage control resuscitation: ABC activation, PROPPR ratios with Bayesian reanalyses, TXA timing gradient with 90-minute refinement, calcium check-and-replace, neutral whole-blood RCTs, targeted fibrinogen, ITACTIC limits, VTE timing and the TBI exception.

clinical3 min readVerification in progress

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
On this page
Study tools

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
Prompt
A 38-year-old is 60 minutes after blunt polytrauma: systolic pressure 84, heart rate 130, positive FAST, lactate 6.1, temperature 35.0, ionised calcium 0.97, 2 units of red cells running. Talk me through activation, ratios, TXA, calcium, whole blood versus components, fibrinogen, viscoelastic testing, what you watch for after haemostasis, and what changes with a severe head injury.

Write your answer

Saved on this device. No marking — you are the marker.

Examiner probes

  1. He is hypotensive with a positive FAST and 2 units running at 60 minutes. Activate or wait — with what score, what ratio, and what do you do when the score says no?[32][5]
  2. TXA — exact dose, the three timing bands with numbers, the 90-minute refinement, and what happens if you miss the window?[16][17][18]
  3. Calcium 0.97 with citrated products running — replace, ignore, or protocol-bolus? Defend with both directions of the evidence.[21]
  4. Whole blood or components at this pressure — and fibrinogen for everyone or for the low? Answer with the 2026 trials and CRYOSTAT-2.[12][13][28][29]
  5. Viscoelastic testing and permissive hypotension — superiority or adjunct, and what changes with a severe head injury?[25][3]

Model responses

1. Activate now — equal ratios fast, scored formally but never vetoed by the score. Hypotension with a positive FAST and blood running is DCR on physiology: score the four ABC variables (penetrating, FAST-positive, systolic 90 or less, pulse 120 or more) while transfusing equal amounts of red cells, plasma and platelets in the early empiric phase.[32][5] Run PROPPR-honest: no mortality difference at 24 hours or 30 days, fewer exsanguinations, more haemostasis, complications equal — with Bayesian reanalyses assigning 93% and 87% probability of 1:1:1 superiority at those endpoints, strongest in the first hours of bleeding.[5][6] And when the ABC totals 1 in a patient clearly bleeding, transfuse anyway: in PROPPR the score managed only 66.8% sensitivity with 37.0% specificity, and gestalt enrolled more than a third of the trial below threshold.[35]

2. TXA 1 g now — inside every window that matters. Give 1 g over 10 minutes then 1 g over 8 hours: CRASH-2 all-cause 14.5% versus 16.0% (RR 0.91), bleeding death 4.9% versus 5.7% (RR 0.85).[16] At 60 minutes he sits in the best gradient band — within 1 hour RR 0.68, 1 to 3 hours RR 0.79, after 3 hours harm RR 1.44 — and inside the PATCH 90-minute optimum (within aRR 0.64, beyond aRR 1.04).[17][18] Missing the window converts benefit toward harm, so the loading dose travels with the first blood, never after the scan or the operation.

3. Check-and-replace calcium — both papers, one practice. Ionised 0.97 meets the verified 1.0-or-less threshold: prehospital plasma pushed hypocalcaemia from 36% to 53% (adjusted RR 1.48), with severe lows predicting decreased survival and massive transfusion — so measure with every round and replace under citrate load.[21] But refuse the fixed-dose protocol claim: in 346 activations 83.2% were hypocalcaemic yet neither first calcium nor citrate-corrected dose touched mortality — the physiology demands vigilance, not a dosing algorithm, and no milligram figure leaves your mouth.[22]

4. Components by default, whole blood by logistics; fibrinogen targeted, never empiric. Two 2026 prehospital randomised trials were neutral — TOWAR 30-day 25.9% versus 20.5% (adjusted OR 1.24), English composite 48.7% versus 47.7% (RR 1.02) — with LTO-WB safety proven (survival 73 versus 74%, post-department products median 0 versus 3, reactions confined to components).[12][13] So choose whole blood where the chain is simplest and balanced components where the bank runs equality well — superiority belongs to neither.[12] Fibrinogen goes only to documented lows with bleeding: empiric 3-pool cryoprecipitate changed 28-day death not at all (25.3 versus 26.1%), while high achieved cryoprecipitate ratios halved adjusted 6-hour mortality (aOR 0.52) — target, never flood.[28][29]

5. VHA advises, hypotension individualises, the injured brain overrules both. Viscoelastic assays see fibrinolysis and fibrinogen failure that conventional tests miss, yet ITACTIC showed no outcome difference (67 versus 64% alive free of massive transfusion; 25 versus 28% dead) with undertreatment explaining more than assay failure — adjunct with honest limits, no cutoff quoted.[25] Permissive hypotension earns its place in hospital (death 6.3 versus 16.3%, blunt 24-hour aOR 0.17, fewer respiratory and organ-failure complications) but not prehospital and never in brain injury.[3] With a severe head injury: normal pressure targets for the brain, TXA by the coma-scale rule (within 2 hours or GCS below 9, benefit possibly persisting), calcium and ratios unchanged — the brain sets the pressure, the clock still sets the drug.[19]

References17ShowHide
  1. [47]Lamb CM, MacGoey P, Navarro AP, et al. Damage control surgery in the era of damage control resuscitation. Br J Anaesth, 2014.PMID 25038156
  2. [32]Nunez TC, Voskresensky IV, Dossett LA, et al. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma, 2009.PMID 19204506
  3. [5]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
  4. [6]Lammers D, Richman J, Holcomb JB, et al. Use of Bayesian Statistics to Reanalyze Data From the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial. JAMA Netw Open, 2023.PMID 36811858
  5. [16]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
  6. [17]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
  7. [18]Ali A, Gruen RL, Bernard SA, et al. Tranexamic Acid Timing and Mortality Impact After Trauma. Ann Emerg Med, 2026.PMID 40751727
  8. [19]Osawa I, Goto T, Roberts I Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials. Br J Surg, 2025.PMID 40277024
  9. [12]Sperry JL, Guyette FX, Cotton BA, et al. Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage. N Engl J Med, 2026.PMID 42150044
  10. [13]Smith JE, Cardigan R, Sanderson E, et al. Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial. N Engl J Med, 2026.PMID 41841706
  11. [21]Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg, 2020.PMID 32317575
  12. [22]Chanthima P, Yuwapattanawong K, Thamjamrassri T, et al. Association Between Ionized Calcium Concentrations During Hemostatic Transfusion and Calcium Treatment With Mortality in Major Trauma. Anesth Analg, 2021.PMID 33646983
  13. [28]Davenport R, Curry N, Fox EE, et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA, 2023.PMID 37824155
  14. [29]Hynes AM, Cannon JW, Yan R, et al. Do not forget the cryoprecipitate: The impact of the 2019 Joint Trauma System Damage Control Resuscitation Clinical Practice Guideline on mortality. J Trauma Acute Care Surg, 2026.PMID 41589734
  15. [25]Baksaas-Aasen K, Gall LS, Stensballe J, et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med, 2021.PMID 33048195
  16. [3]Indorewala Y, Nasef Y, Jayagopi K, et al. Permissive hypotension in adult trauma: A systematic review of outcomes across clinical settings, injury type, and resuscitation strategies. Am J Emerg Med, 2026.PMID 42030689
  17. [35]Baird EW, Lammers DT, Abraham P, et al. Diagnostic performance of the ABC score in the PROPPR trial. Injury, 2024.PMID 38852527
PreviousARDS in the surgical patient — define, ventilate, rescue with the trialssurgical-critical-careNextDIC at the bedside — phenotype, scores, products and the anticoagulant distinctionsurgical-critical-care